High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluoresent proteins
US-2015369800-A1 · Dec 24, 2015 · US
US11255848B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11255848-B2 |
| Application number | US-201715606525-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 26, 2017 |
| Priority date | Apr 19, 2010 |
| Publication date | Feb 22, 2022 |
| Grant date | Feb 22, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition can include a complex, where the complex includes a photoluminescent nanostructure and a polymer free from selective binding to an analyte, the polymer adsorbed on the photoluminescent nanostructure, and a selective binding site associated with the complex.
Opening claim text (preview).
What is claimed is: 1. A composition, comprising: a polymer-nanostructure complex including: a photoluminescent nanostructure wherein the nanostructure is a single-walled carbon nanotube; and a polymer including 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lauroyl), the polymer adsorbed on the nanostructure via non-covalent interactions and the polymer being free from selective binding to an analyte in the absence of being adsorbed on the nanostructure such that the polymer adsorbed on the nanostructure forms a selective binding site that recognizes the analyte, the polymer-nanostructure complex structure as a binding partner for the analyte, which results in a detectable change in photoluminescence. 2. The composition of claim 1 , wherein the polymer further includes polyvinylpyrrolidone, poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block co-polymer, a poly(ethylene oxide), poly(N-isopropyl acrylamide), polyethyleneimine, polyacrylamide, polyvinyl alcohol or collagen. 3. The composition of claim 1 , wherein the polymer further includes a dye conjugate or a branched polymer. 4. The composition of claim 1 , wherein the analyte is a monosaccharide, a polysaccharide, an amino acid, a nucleotide, an oligonucleotide, a lipid, a polylipid, a steroid, a peptide, a protein, riboflavin, or nitric oxide. 5. The composition of claim 1 , wherein the analyte is 17-a-estradiol, 2,4-dinitrophenol, acetylcholine chloride, a-tocopherol, adenosine, adenosine-5′-triphosphate, cyclic adenosine monophosphate, creatinine, cytidine, D-aspartic acid, D-fructose, D-galactose, D-glucose, D-mannose, dopamine, glycine, guanosine, histamine, L-ascorbic acid, L-citrulline, L-histidine, L-thyroxine, melatonin, NADH, quinine, salicylic acid, serotonin, sodium azide, sodium pyruvate, sucrose, thymidine, tryptophan, tyramin or urea.
with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title
Nanotechnology for materials or surface science, e.g. nanocomposites · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.